🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Mizuho lifts Alcon stock target on strong lens outlook

EditorAhmed Abdulazez Abdulkadir
Published 05/16/2024, 07:35 AM
ALC
-

On Thursday, Mizuho Securities adjusted its outlook for Alcon Inc. (NYSE: NYSE:ALC), a leader in eye care products, by increasing the company's price target from $100.00 to $105.00. The firm sustained its Buy rating on the stock, reflecting a positive view of the company's recent performance and future prospects.

The revision follows Alcon's first-quarter earnings call, where the company reported an 11% constant currency growth in its contact lens segment, outpacing the underlying market's growth of 7%. This gain is attributed to both price increases and share gains. Additionally, Alcon saw a year-over-year uptick of 130 basis points in the global penetration of its advanced technology intraocular lenses (AT-IOLs), particularly in markets outside the United States.

Despite a slowdown in global cataract procedures, which grew by 2% year-over-year including a 1% growth in the U.S., Alcon's AT-IOL penetration rates have been robust, initially ranging between 300 to 400 basis points during the early stages of its PanOptix/Vivity product cycles. The company anticipates these rates will stabilize to an increase of around 50 basis points moving forward.

Alcon's strong first-quarter margin profile was also highlighted, with margins reaching 23.5%, significantly surpassing the full-year guidance of 20.5-21.5%. The company's financial outlook remains solid despite anticipated headwinds from foreign exchange rates and research and development expenses.

InvestingPro Insights

Following Mizuho Securities' positive adjustment to Alcon Inc.'s price target, InvestingPro data further enriches the perspective on the company's financial health and market standing. Alcon, with a market capitalization of $44.36 billion and a P/E ratio of 42.36, shows a substantial valuation that reflects its leading position in the eye care industry. The company's revenue growth over the last twelve months as of Q1 2024 stands at 7.68%, demonstrating its ability to expand despite market fluctuations.

Significant to Alcon's investment profile is its dividend track record, with the company having raised its dividend for four consecutive years, highlighting a commitment to shareholder returns. Additionally, Alcon's stock has experienced a significant return over the last week, with a price total return of 10.68%, indicating strong recent performance in the market.

For investors looking for deeper insights and additional metrics, there are over ten InvestingPro Tips available, including analysis on earnings revisions, stock volatility, and industry positioning. To access these insights and enhance your investment strategy, consider using the coupon code PRONEWS24 for an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.